ARKG vs VAW
ARK Genomic Revolution ETF vs Vanguard Materials ETF
ARKG$43.17
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
VAW$225.58
Vanguard Materials ETF
US materials sector stocks.
Expense: 0.09%Yield: 1.39%
Quick take
- • VAW has the lower expense ratio at 0.09% vs 0.75% for ARKG.
- • VAW pays a higher dividend yield (1.39%).
Side-by-side metrics
| Metric | ARKG | VAW |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.09% |
Dividend yield Trailing 12-month yield. | 0.00% | 1.39% |
AUM Assets under management — bigger funds are typically more liquid. | $1.73B | $4.49B |
YTD return | 44.53% | 8.48% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.38 | 0.91 |
P/E ratio | — | 24.08 |
Last price | $43.17 | $225.58 |
Inception | — | — |
Issuer | ARK | Vanguard |
ARKG top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 9.15% |
| TEM | Tempus AI Inc Class A common stock | 7.64% |
| ABSI | Absci Corp | 7.01% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 7.00% |
| CRSP | CRISPR Therapeutics AG | 6.56% |
| PSNL | Personalis Inc | 6.19% |
| BEAM | Beam Therapeutics Inc | 4.34% |
| GH | Guardant Health Inc | 4.28% |
| NTRA | Natera Inc | 4.11% |
| ILMN | Illumina Inc | 3.98% |
Sector breakdown · ARKG
Healthcare100.0%
VAW top holdings
Top holdings · VAW
| LIN | Linde PLC | 14.78% |
| NEM | Newmont Corp | 7.60% |
| FCX | Freeport-McMoRan Inc | 6.05% |
| CRH | CRH PLC | 4.67% |
| SHW | Sherwin-Williams Co | 4.58% |
| ECL | Ecolab Inc | 4.17% |
| APD | Air Products and Chemicals Inc | 3.61% |
| NUE | Nucor Corp | 3.56% |
| CTVA | Corteva Inc | 3.37% |
| VMC | Vulcan Materials Co | 2.37% |
Sector breakdown · VAW
Consumer Cyclical8.3%
Basic Materials90.1%
Consumer Defensive0.0%
Industrials1.1%
Energy0.0%
Healthcare0.5%
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 9.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About VAW
VAW (Vanguard Materials ETF) is US materials sector stocks. Managed by Vanguard, the fund carries $4.5B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.39%. Its largest holding is Linde PLC (LIN), which represents 14.8% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 8.3%.